Thirty eight hGH deficient patients aged from 15 to 35 yrs in whom hGH therapy was stopped upon termination of growth, were re-evaluated for their social adjustment by personal interviews. The mean length of treatment period was 6.7 2 3.2 (1.6-14) yrs, which had begun in 80% of the patients after age 9. It was found that 10 are students (7 in secondary school and 3 at the university); 7 are now serving in the army (another 6 completed army service); 18 have jobs with tenure; 3 are unemployed. Of the entire group, 4 (1 man, 3 women) are married. The successful social and vocational adjustment is attributed to the continuous multidisciplinary team approach these patients had received throughout their follow-up.
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Comparison o f growth hormone (GH) sleep s e c r e t i o n and responses t o pharmacological t e s t s .
GH s e c r e t i o n was s t u d i e d d u r i n g sleep i n 37 s h o r t p a t i e n t s (28 males and 9 females) w i t h h e i g h t from -2 t o -6.5 SD. No cause o f growth r e t a r d a t i o n was known i n anyone o f them. A concommitant complete endocrine e v a l u a t i o n was done everytime w i t h a t l e a s t two pharmacological t e s t s , using o r n i t h i n e , a r g i n i n e and/or i n s u l i n . The major GH sleep peak l e v e l (SP) was compared t o t h e major GH pharmacological peak l e v e l (PP). SP ranged from 2.9 t o 46 ng/ml (mean + SD = 15.8 +_ 11 ng/ml) and PP from 4 t o 30 ng/ml (mean i S D = 13.9 58.3 ng/m7). SP and PP were c o r r e l a t e d , r = 0.50 ( p < 0.01). SP was c o n s i s t a n t l y below 10 ng/ml when PP was below 6 ng/ml. However, i f i n d i v i d u a l values o f SP and PP were i n t h e same range i n 23 p a t i e n t s (12 normal, 5 b o r d e r l i n e and 6 blunted), they showed discrepancies i n 14 : a l a c k o f SP i n s p i t e o f a normal o r b o r d e r l i n e PP i n 3 o r t h e c o n t r a r y i n 2, and a b o r d e r l i n e SP i n s p i t e o f a normal PP i n 3 o r t h e c o n t r a r y i n 6. T h i s shows t h a t i n very s h o r t c h i l d r e n , a normal o r b o r d e l i n e GH response t o pharmacological s t i m u l i does n o t prelude a l a c k o r an i n s u f f i c i e n c y of GH sleep secretion. I n such cases, measurement of GH sleep s e c r e t i o n may o f f e r a r a t i o n a l e f o r a t r i a l course o f hGH treatment. 
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Enfants-Malades, Parls, France. Influence of age at lrradlatlon on the occurrence of GH deficiency In chlldren recelvlng 2400 rods on the braln for acute lymphoblastlc leukemla(ALL) or lymphosarcoma(LS) I t has been shown that after cranial lrradlation for ALL (2400 rods), the peak plasma GH response after stlmulatlon can be reduced but often without decrease growth velocity. The purpose of thls study was to evaluate the frequency of GH deflclency, Its relatlonshlp to growth and the posslble effect of age at Irradlation. Children (n=36 : 27 ALL, 9 LS) who had been exposed to a slmllar cranlal radlatlon (12 x 200 rods over 16 days), were lnvestlgated ; chemotherapy had been termlnated In 27. Two groups were dlstlngulshed according to GH peak values (ng/ml) after AITT: Group 1<8 and Group 11>8 ; the others parameters, lncludlng chemotherapy and Interval time slnce lrradlatlon (respectively 5 7/12 + 7/12 and 5 4/12 + 7/12 yr) are slmllar In these two groups. Groua n Aae Irradiation (vr) Decr.arouth velocltv(n) I 21 5-2/12+ 6/12 (~' + s E M ) 15 l l 15 8 4/12 + 11/12 ** 3 In arouo I. GH defTclencv was com~lete (13) or ~artlal (8). In -7 , thls group, chi ldren had'been lrrbdlated at a slgnlf lcantly younger age (p< 0.01).
Correction of obstructive sleep apnea and sleep entrained growth hormone release by tracheostomy in achondroplasia.
Obstructive sleep apnea (OSA) may occur in patients with achondroplasia. Since the bulk of growth hormone (GH) is secreted in relation to slow wave sleep (SWS), disordered sleep may hinder GH release and subsequent growth. To examine these relationships, a 9 yr old prepubertal male achondroplastic dwarf with growth failure and OSA was studied with polysomnography and q 20 min sampling for sleep entrained GH before and 4 mos. after therapeutic tracheostomy (T) . 3 2480 Integrated 24h hGH concentration (IC-hGH) was elevated in the 2 teenager LTD females and at the upper limit of normal in the young LTD male. The metabolic clearance rate (MCR) was lower in the 2 LTD patients studied than in normal subjects, as in patients with hGH deficiency. The production rate (PR) was elevated in the girl (within the range of acromegaly) whereas in the young man it was only slightly elevated. All 3 LTD patients showed secretory 24h patterns having more frequent and greater fluctuations than in normals. In view of recent findings that the primary defect in LTD is an inability of liver receptors to bind hGH, causing a lack
In conclusion, GH deficiency 1) Is a frequent compllcatlon ; of somatomedin (sM), it is sugges;ed that the enhancement and 2 ) determinesfrequently decrease growth veloclty ; 3 ) Is more irregularity of hGH secretion in LTD is due to a dual mechanism, Ilkelv to occur In children when lrradlatlon Is ~erformed at a both pathways being related to SM deficiency: 1) lack of negative . ~ r --~ younger age. feedback on pituitary hGH and possibly on GH-RH: 2) lack of stimulating effect on somatostatin secretion.
